CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

Sponsored by CeloNova BioSciences, Inc.

cit | Article | September/October 2020

Clinical Decision-Making for PCI Patients During the COVID-19 Pandemic

With Aloke Finn, MD; Rajiv Jauhar, MD, FACC, FSCAI; and S. Jay Mathews, MD, MS, FACC

cit | News | June 28, 2022

Advanced NanoTherapies Closes Series A Financing to Support FIH Clinical Study of SirPlux Duo DCB

June 28, 2022—Advanced NanoTherapies, Inc. announced the closing of its oversubscribed $7.2 million Series A equity financing, marking a total of $12.5 million raised since September 2020.

cit | News | January 7, 2020

Proximo Medical Named Commercialization Partner for CeloNova BioSciences in Select United States Markets

January 8, 2020—Proximo Medical, LLC, announced a partnership in select United States markets with CeloNova Biosciences, Inc. Proximo Medical is a fractional commercial organization for start-up medical device technologies and established medical device companies looking to expand adoption in the United States.

cit | News | May 13, 2021

Final 5-Year Results Revealed From CeloNova’s PzF SHIELD Trial of Highly Complex PCI Patients

May 13, 2021—CeloNova BioSciences, Inc. announced the final results of the company’s global, multicenter PzF SHIELD investigational device exemption clinical trial of highly complex patients undergoing percutaneous coronary intervention (PCI).

Advertisement

Advertisement

Sponsored by Abbott

cit | Article | May/June 2019 Supplement

The Role of Stent Biomaterials In Reducing DAPT Duration

Expert commentary on the roles of technology and pharmacology.

By Hiroyuki Jinnouchi, MD; Renu Virmani, MD; and Aloke V. Finn, MD

cit | Article | September/October 2018

Dyspnea in a Diabetic Patient With Previous TAVR

Moderator: Franz X. Kleber, MD
Panel: Finn Gustafsson, MD, PhD, and Felix Mahfoud, MD

cit | Article | May/June 2010

Drug-Coated Balloons for Coronary Artery Disease

A discussion on the current state of drug-coated balloons and their use for the prevention of in-stent restenosis.

By Juan F. Granada, MD, and William A. Gray, MD

cit | Article | May/June 2010

Do Improvements in Stent Technology Affect Stent Thrombosis?

A review of the literature on the safety of first- and second-generation drug-eluting stents.

By Amjad T. Almahameed, MD, MPH, and Donald E. Cutlip, MD

cit | Article | January/February 2011

The Current Role of Bare-Metal Stents

An evaluation of the importance of BMS in contemporary practice.

By Itsik Ben-Dor, MD; Ron Waksman, MD; Augusto D. Pichard, MD; Joseph Lindsay, MD; and Lowell F. Satler, MD

Sponsored by ACIST

cit | Article | July/August 2022

Ultra-Low Contrast Imaging and PCI

Minimizing contrast volume in angiography and PCI.

By Ziad A. Ali, MD, DPhil

cit | Article | January/February 2013

Potential Use of OCT Imaging in Clinical Practice

From preintervention to postprocedure follow-up, the utility of optical coherence tomography assessment is examined.

By Daniel Chamié,, MD, and Ricardo A. Costa, MD, PhD

cit | Article | March/April 2011

Post-PCI Selection of Antithrombotic Therapy

Improvements in antithrombotic pharmacotherapy have led to important reductions in complications after percutaneous coronary intervention.

By John P. Vavalle, MD, and Robert A. Harrington, MD

cit | Article | April 2008

Improving Patient Outcomes After PCI Without Long-Term, Dual-Antiplatelet Therapy

Advancing the value of stent system technology.

cit | Article | September/October 2013

A New Analysis of the COURAGE Trial

Experts weigh in with their opinions of a new analysis looking at crossover patients.

With John Spertus, MD, MPH, FACC, FAHA; William Fearon, MD; and Ralph G. Brindis, MD, MPH, MACC, FSCAI

cit | Article | January/February 2021

Appraising the Role of PFO Closure

A review of updated trial data, available devices, and application of patent foramen ovale closure.

By Krishna S. Kallakuri, MD, and Rajeev L. Narayan, MD

cit | Article | March/April 2012

Using Fractional Flow Reserve in Complex Lesions

FFR overcomes other technologies' shortcomings to fine-tune clinical decisions for challenging cases.

By Mouhamad H. Abdallah, MD; Carlos Sanchez, MD; and Massoud A. Leesar, MD, FACC, FSCAI

cit | Article | July/August 2010

Balloon Aortic Valvuloplasty in the TAVI Era

A review of current technique and uses in stand-alone, bridging, and predilation settings.

By Wes R. Pedersen, MD, FACC, FSCAI; Irvin F. Goldenberg, MD, FACC, FSCAI; and Ted E. Feldman, MD, FESC, FACC, FSCAI

cit | Article | October/November 2008

Understanding the COURAGE Trial

Where does the controversial clinical trial fit in current interventional practice?

By Kimberly A. Skelding, MD, FSCAI, and Bonnie h. Weiner, MD, MSEC, MBA, FSCAI

Sponsored by Arstasis

cit | Article | September/October 2012

Novel Access Technology Providing Implant-Free Femoral Artery Closure

An introduction to applying this Axera technology in your practice.

By Jaafer Golzar, MD, FACC, FSCAI


1
2
3
4

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button